Valuation: Abbott Laboratories

Market Cap 19TCr 17TCr 16TCr 14TCr 27TCr 18,31600Cr 27TCr 1,83600Cr 72TCr 9,16900Cr 72TCr 70TCr 30,58600Cr P/E 2026 *
31.8x
P/E 2027 * 24.5x
Enterprise Value 22TCr 19TCr 18TCr 16TCr 30TCr 20,60100Cr 31TCr 2,06500Cr 81TCr 10,31200Cr 81TCr 79TCr 34,40100Cr EV / Sales 2026 *
4.29x
EV / Sales 2027 * 3.9x
Free-Float
86.16%
Yield 2026 *
2.32%
Yield 2027 * 2.47%
1 day+0.04%
1 week+2.78%
Current month+4.98%
1 month+20.46%
3 months+32.36%
6 months-1.53%
Current year-11.44%
1 week 106.01
Extreme 106.01
112.47
1 month 87.64
Extreme 87.64
112.47
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

416 0.0000%
30/06/26 Free

Director

432 0.0000%
30/06/26 Free

Director

363 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.03%+2.78%-14.25%+4.58% 19TCr
-0.12%+5.67%-2.28%+9.18% 12TCr
-1.21%-3.98%+7.22%+66.32% 6TCr
+2.11%+2.55%+34.34%+62.10% 5.46TCr
-0.63%+3.12%-6.82%-35.40% 5TCr
+0.46%+9.92%+14.13%-21.17% 3.43TCr
+1.75%+4.03% - - 3.11TCr
-1.55%-0.30%+41.16%-13.08% 2.48TCr
+0.85%+14.53%-3.89%+20.23% 2.41TCr
-0.32%+1.67%-4.62%+2.84% 2.31TCr
Average +0.15%+4.04%+7.22%+10.62% 6.1TCr
Weighted average by Cap. +0.10%+4.20%+0.47%+12.17%

Financials

2026 *2027 *
Net sales 5.03TCr 4.36TCr 4.09TCr 3.73TCr 7.01TCr 4,80100Cr 7.13TCr 48TCr 19TCr 2,40300Cr 19TCr 18TCr 8,01700Cr 5.46TCr 4.74TCr 4.44TCr 4.05TCr 7.62TCr 5,21600Cr 7.74TCr 52TCr 20TCr 2,61100Cr 21TCr 20TCr 8,70900Cr
Net income 623.05Cr 540.06Cr 506.27Cr 461.62Cr 868.57Cr 59TCr 882.49Cr 5.96TCr 2.33TCr 30TCr 2.34TCr 2.29TCr 99TCr 793.42Cr 687.73Cr 644.7Cr 587.84Cr 1.11TCr 76TCr 1.12TCr 7.59TCr 2.96TCr 38TCr 2.98TCr 2.91TCr 1,26400Cr
Net Debt 2.39TCr 2.08TCr 1.95TCr 1.77TCr 3.34TCr 2,28500Cr 3.39TCr 23TCr 8.94TCr 1,14400Cr 8.99TCr 8.79TCr 3,81500Cr 2.1TCr 1.82TCr 1.7TCr 1.55TCr 2.92TCr 2,00000Cr 2.97TCr 20TCr 7.83TCr 1,00100Cr 7.87TCr 7.7TCr 3,34000Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change Volume
14/26/14 $111.03 +0.11% 31,51,354
12/26/12 $110.91 +1.08% 66,13,696
11/26/11 $109.72 +1.01% 67,44,803
10/26/10 $108.62 +0.75% 56,03,218
07/26/07 $107.81 -0.14% 66,06,637
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
110.91USD
Average target price
118.42USD
Spread / Average Target
+6.77%

Quarterly revenue - Rate of surprise